text.skipToContent text.skipToNavigation
Pharma & Biotech

Fresh Human CD8+/CD45RA+ Naive Cytotoxic T Cells (Untouched)

Catalog #: 3W-302
Human CD8+/CD45RA+ naive cytotoxic T cells, isolated from peripheral blood using negative immunomagnetic selection, ≥ 5 million cells, fresh
Compare
EA

Product Overview

Leukapheresed Naïve CD8+ T cells are isolated using a two step isolation process. CD8+ T Cells are first negatively selected from MNC using an indirect immunomagnetic CD8+ labeling system. CD45RO microbeads are then used to deplete the CD45RO+ population, leaving a highly enriched CD4+ CD45RA+ Naïve T Cell population. Cells are shipped in a transport vial. Cell purity is determined using a FACS assay. Count and viability is determined using AO/PI. Cells are collected from healthy donors following IRB protocols. Manufactured by AllCells® Additional shipping charges apply for fresh, human origin products

Content & Storage

Content

1 vial containing ≥ 5 million fresh cells

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Need a Quote or Any Support?

Request a local representative to get back to you with additional information or pricing.

Immunotherapy and Hematopoietic Knowledge Center

The Immunotherapy and Hematopoietic Knowledge Center is dedicated to sharing interesting articles and resources related to immuno and hematopoietic research.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok